Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) approved KEYTRUDA ® (pembrolizumab) and KEYTRUDA QLEXâ„¢ ...
New research suggests glucosamine may have unexpected effects in people with mild to severe cognitive impairment ...
Facebook Twitter WhatsApp SMS Email Print Copy article link Save Purchase Article Reprint A new federal housing bill could ...
South Korea is enforcing a law that allows steep punitive damages against news outlets and social media influencers for spreading false information as journalist groups warned it could chill public ...
Federal officials may remove warnings on testosterone therapy drugs about heart and prostate risks, which could expand access ...
Facebook Twitter WhatsApp SMS Email Print Copy article link Save Purchase Article Reprint Several new laws took effect in ...